A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation
about
NTDs V.2.0: "blue marble health"--neglected tropical disease control and elimination in a shifting health policy landscape.Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of wormsShrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide MappingControlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their SuccessShort-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.The contribution of mass drug administration to global health: past, present and future.Lessons from implementing mass drug administration for soil transmitted helminths among pre-school aged children during school based deworming program at the Kenyan coastA systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.A case study of risk factors for lymphatic filariasis in the Republic of Congo.The conceptual framework and assessment methodology for the systematic reviews of community-based interventions for the prevention and control of infectious diseases of povertyThe global distribution and transmission limits of lymphatic filariasis: past and present.Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.This de-wormed world?Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program VolunteersThe impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administrationTransmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana.The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020Essential proteins and possible therapeutic targets of Wolbachia endosymbiont and development of FiloBase--a comprehensive drug target database for Lymphatic filariasis.Ongoing surveillance for lymphatic filariasis in Togo: assessment of alternatives and nationwide reassessment of transmission status.Neglected tropical diseases in Africa: a new paradigm.Ivermectin: a complimentary weapon against the spread of malaria?Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.[Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission.Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo.
P2860
Q21562238-5A5CBA93-B55D-4444-A929-217488CE8F86Q26998808-58CF35B0-59A3-4748-BE51-581FEC5922F4Q28550723-14CCA5F2-257B-42DA-BAA0-011D498FDB46Q28554503-A0F56CB6-E727-4E01-BC99-29DCFD335621Q30377066-486A1539-B4E6-4CCE-A245-594BE837499CQ30388508-9B19ADBD-28FD-4439-8877-92AD2E006245Q30855808-E5F83444-91B6-4C74-9E92-7ABAEF77430CQ33717067-B4C402A3-A109-4AF0-B7E2-0EE42A5CE0D9Q33874155-4621AE51-B0C8-4599-8EC2-9916E43A5484Q34014984-2D90CD4C-9BFC-44C7-BCE3-88FCC0A09C13Q34340088-EA96646F-B04F-4761-820B-938EEE274FF6Q34517923-40211AB2-D533-44D0-AF4B-C07582550983Q34986489-4D72D49F-0E31-448C-ACBC-25F289A232A6Q35915701-6CB87200-5CC5-4A8A-9944-3E67907A8A8AQ36088925-BD7BDDE3-54E3-4C2C-8922-1A300DE5B522Q36219421-0CDEB1A3-D173-47D9-AE9C-53E69C8DCE34Q36264896-0C2FFFC4-466C-4D0F-9053-22EF6C921D8FQ36500880-B390BF0E-9B82-46B0-8E48-63E35254D021Q37456194-41C9655E-27D6-4584-B1D8-C67AA3044788Q38759662-57B90970-2A19-4133-AFD3-4FB77CDADD09Q40411509-0708E264-CCDB-4376-B35F-170B714EAAC4Q42366319-EB6E2F9F-7023-416D-9CD8-FA0F072ABC31Q44288385-E7492E5C-D332-4354-96CB-F03DA8BD5934Q46198405-65BBA172-C6A2-4BD2-8E30-8C47848A02E8Q46716665-34D6ED1A-5B54-4C4F-822E-B1426777874CQ50334954-F4C0671D-B998-4CB4-8811-E0041FFFDBF9Q55133116-016DFCF9-1393-4855-B04A-9E2EE6F19B6F
P2860
A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A success story: Togo is movin ...... ntrywide morbidity alleviation
@ast
A success story: Togo is movin ...... ntrywide morbidity alleviation
@en
A success story: Togo is movin ...... ntrywide morbidity alleviation
@nl
type
label
A success story: Togo is movin ...... ntrywide morbidity alleviation
@ast
A success story: Togo is movin ...... ntrywide morbidity alleviation
@en
A success story: Togo is movin ...... ntrywide morbidity alleviation
@nl
prefLabel
A success story: Togo is movin ...... ntrywide morbidity alleviation
@ast
A success story: Togo is movin ...... ntrywide morbidity alleviation
@en
A success story: Togo is movin ...... ntrywide morbidity alleviation
@nl
P2093
P2860
P921
P3181
P1476
A success story: Togo is movin ...... ntrywide morbidity alleviation
@en
P2093
Ameyo Monique Dorkenoo
Anders Seim
Kodjo Morgah
Komlan Nabiliou
Kossivi Agbo
Michel Datagni
Rebecca Miller
Yao K Sodahlon
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002080
P407
P50
P577
2013-01-01T00:00:00Z